Skip to main content

Table 3 Proportions of physicians adhering to the guidelines for diabetes management for patients with cardiovascular risk

From: Adherence of physicians to evidence-based management guidelines for treating type 2 diabetes and atherosclerotic cardiovascular disease in Ajman, United Arab Emirates

Management of T2DM with cardiovascular risk Proportion 95% CI
Prescription of SGLT2 109 (50%) 43.3–56.7
Prescription of GLP-1 47 (21.6%) 16.1–27.1
Overall adherence 122 (56%) 49.3–62.6
  1. Abbreviations: GLP-1 Glucagon-like peptide 1 agonist, SGLT2 Sodium-glucose cotransporter 2 inhibitor